Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants-Reference-Cited by-同舟云学术

Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants

Published:2013-08-07 Issue:6 Volume:113 Page:419-424
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Cha Yu-Jung¹,Lee Howard²,Gu Namyi¹,Kim Tae-Eun¹,Lim Kyoung S.¹,Yoon Seo H.¹,Chung Jae-Yong¹,Jang In-Jin¹,Shin Sang-Goo¹,Yu Kyung-Sang¹,Cho Joo-Youn¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine; Seoul National University Hospital; Seoul Korea

2. Clinical Trials Center; Seoul National University Hospital; Seoul Korea

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12108/fullpdf

Reference21 articles.

1. P-glycoprotein inhibition;Darby;Curr Drug Metab,2011

2. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples;Canaparo;Basic Clin Pharmacol Toxicol,2007

3. Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol;Kanaan;Basic Clin Pharmacol Toxicol,2009

4. Modulation of P-glycoprotein mediated multidrug resistance (MDR) in cancer using chemosensitizers;Velingkar;Int J Pharma Sci Res,2010

5. Multidrug resistance in cancer;Gottesman;Nat Rev Cancer,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions;Pharmaceutical Research;2023-07-31

2. Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers;Therapeutic Advances in Drug Safety;2023-01

3. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

4. Canine and feline P‐glycoprotein deficiency: What we know and where we need to go;Journal of Veterinary Pharmacology and Therapeutics;2022-11-03

5. A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignancies;Cancer Chemotherapy and Pharmacology;2022-07-29